Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Transfusion in Decompensated Liver Cirrhosis
NCT03529136Phase 2Unknown
- Sponsor
- Shandong Qilu Stem Cell Engineering
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in Liver cirrhosis (LC), sponsored by Shandong Qilu Stem Cell Engineering. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03529136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03529136.